Recent advances in the management of chronic heart failure.
BACKGROUND
The management of chronic heart failure (CHF) has undergone a revolution in the past decade, highlighted by dramatic turnarounds in opinion, renewed focus on 'traditional' therapies and the emergence of novel diagnostic and treatment options.


OBJECTIVE
Based on review of the current evidence, this article aims to provide an update of the issues pertaining to the diagnosis and treatment of CHF.


CONCLUSIONS
Underlying this revolution on the management of CHF have been novel insights into the pathophysiology of CHF. Promising findings from recent clinical trials will also be examined in this article.
Krum
Henry
H
Clinical Pharmacology Unit, Department of Epidemiology and Preventive Medicine, Monash University Medical School, Alfred Hospital, Melbourne, Vic 3004. henry.krum@med.monash.edu.au
Liew
Danny
D
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002908:Chronic Disease; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D018754:Ventricular Dysfunction / Q000188:drug therapy / Q000453:epidemiology
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors